SynthesisNeuroradiology2021
Radiological prognostic factors of chronic subdural hematoma recurrence: a systematic review and meta-analysis.
Synthesis in Neuroradiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 2 registered trials, which are not on this map. Cited by 59 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
TRACE STUDY: A Randomized Controlled Trial Using Tranexamic Acid in the Treatment of Subdural Hematoma
Puerto Rico Embolization of the Middle Meningeal Artery for the Treatment of Chronic Subdural Hematoma Trial (PREMMA)
Who cites it
59 citing papers in PubMed, 2 syntheses or guidelines pooled it, 121 citations in OpenAlex.
- Risk factors for recurrence of chronic subdural hematoma after surgical evacuation: a systematic review and meta-analysis.Neurosurgical review · 2023Pooled it
- Nontraumatic subdural hematoma in patients on hemodialysis with end-stage kidney disease: a systematic review and pooled analysis.Frontiers in neurology · 2023Pooled it
- Factors Affecting Chronic Subdural Hematoma Recurrence after Middle Meningeal Artery Embolization.Asian journal of neurosurgery · 2026Article
- Chronic Subdural Hematoma: Pathophysiology, Diagnosis, and the Emerging Role of Middle Meningeal Artery Embolization.Journal of clinical medicine · 2026Review
- Decision making in chronic subdural haematoma patient referrals in an octogenarian and nonagenarian population - a multi-centre perspective.Irish journal of medical science · 2026Article
- Article
- Article
- Delayed evacuation of bilateral chronic subdural hematoma with herniation-induced bilateral posterior cerebral artery infarction: illustrative case.Journal of neurosurgery. Case lessons · 2026Article
- Middle meningeal artery embolization in chronic subdural hematoma: bridging surgical innovations and molecular mechanisms.Frontiers in surgery · 2026Review
- Role of the postoperative subdural space and midline shift in predicting chronic subdural hematoma recurrence: A single-center study.Surgical neurology international · 2026Article
- Hematoma Capsule Spanning the Sylvian Fissure and Non-Blocking the Middle Meningeal Artery During Surgery Are Associated With Postoperative Recurrence of Chronic Subdural Hematoma.International journal of general medicine · 2026Article
- Volume and Attenuation Characteristics of Chronic Subdural Hematoma: An Annotated Patient Cohort of 257 Patients with Interrater Reliability Assessments.Tomography (Ann Arbor, Mich.) · 2025Article
- Volumetric assessment in chronic subdural hematoma: a predictor of recurrence and guide for adjunctive therapy.Neurosurgical review · 2025Article
- Consensus Statement on Middle Meningeal Artery Embolization in Chronic Subdural Hematoma Treatment: A Guideline from the Society of Vascular and Interventional Neurology Guidelines and Practice Standards Committee.Stroke (Hoboken, N.J.) · 2025Review
- Nonsurgical Treatment of Chronic Subdural Hematoma Patients with Chinese Medicine: Case Report Series.Chinese journal of integrative medicine · 2025Article
- Impact of surgical timing on chronic subdural hematoma outcomes: novel insights from a multicenter study.Neurosurgical review · 2025Article
- Surgeon-specific differences in recurrence rates among patients undergoing burr hole evacuation for chronic subdural hematoma.Brain & spine · 2025Article
- Risk Factors of Chronic Subdural Hematoma Recurrence: A Systematic Review.Medical journal of the Islamic Republic of Iran · 2025Review
- Management of chronic subdural hematoma in spontaneous intracranial hypotension.Brain & spine · 2025Article
- Comparative clinical outcomes of irrigation techniques in burr-hole craniostomy for chronic subdural hemorrhage: a multicenter cohort study.European journal of trauma and emergency surgery : official publication of the European Trauma Society · 2024Article
Corrections and comments
- Erratum issued
Authors and funding
10 authors at 5 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeChronic subdural hematoma (CSDH) is associated with high recurrence rates. Radiographic prognostic factors may identify patients who are prone for recurrence and who might benefit further optimization of therapy. In this meta-analysis, we systematically evaluated pre-operative radiological prognostic factors of recurrence after surgery.
methodsElectronic databases were searched until September 2020 for relevant publications. Studies reporting on CSDH recurrence in symptomatic CSDH patients with only surgical treatment were included. Random or fixed effects meta-analysis was used depending on statistical heterogeneity.
resultsTwenty-two studies were identified with a total of 5566 patients (mean age 69 years) with recurrence occurring in 801 patients (14.4%). Hyperdense components (hyperdense homogeneous and mixed density) were the strongest prognostic factor of recurrence (pooled RR 2.83, 95% CI 1.69-4.73). Laminar and separated architecture types also revealed higher recurrence rates (RR 1.37, 95% CI 1.04-1.80 and RR 1.76 95% CI 1.38-2.16, respectively). Hematoma thickness and midline shift above predefined cut-off values (10 mm and 20 mm) were associated with an increased recurrence rate (RR 1.79, 95% CI 1.45-2.21 and RR 1.38, 95% CI 1.11-1.73, respectively). Bilateral CSDH was also associated with an increased recurrence risk (RR 1.34, 95% CI 0.98-1.84). LIMITATIONS: Limitations were no adjustments for confounders and variable data heterogeneity. Clinical factors could also be predictive of recurrence but are beyond the scope of this study.
conclusionsHyperdense hematoma components were the strongest prognostic factor of recurrence after surgery. Awareness of these findings allows for individual risk assessment and might prompt clinicians to tailor treatment measures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.